FI853649A0 - Foerfarande foer framstaellning av farmaceutiskt aktiva 2-(pyridylalkensulfinyl)benzimidazoler. - Google Patents

Foerfarande foer framstaellning av farmaceutiskt aktiva 2-(pyridylalkensulfinyl)benzimidazoler.

Info

Publication number
FI853649A0
FI853649A0 FI853649A FI853649A FI853649A0 FI 853649 A0 FI853649 A0 FI 853649A0 FI 853649 A FI853649 A FI 853649A FI 853649 A FI853649 A FI 853649A FI 853649 A0 FI853649 A0 FI 853649A0
Authority
FI
Finland
Prior art keywords
pyridylalkensulfinyl
benzimidazoler
active
fruit protection
activation
Prior art date
Application number
FI853649A
Other languages
English (en)
Other versions
FI853649L (fi
Inventor
John Charles Sih
Moo Jung Cho
Original Assignee
Uppjohn Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uppjohn Company filed Critical Uppjohn Company
Publication of FI853649A0 publication Critical patent/FI853649A0/fi
Publication of FI853649L publication Critical patent/FI853649L/fi
Priority to FI915516A priority Critical patent/FI915516A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI853649A 1984-09-24 1985-09-23 Foerfarande foer framstaellning av farmaceutiskt aktiva 2-(pyridylalkensulfinyl)benzimidazoler. FI853649L (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI915516A FI915516A0 (fi) 1984-09-24 1991-11-22 Foerfarande foer framstaellning av farmaceutiskt aktiva 2-pyridylalkensulfinyl) benzimidazoler.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US65399984A 1984-09-24 1984-09-24
US68298084A 1984-12-18 1984-12-18
US76123985A 1985-07-31 1985-07-31

Publications (2)

Publication Number Publication Date
FI853649A0 true FI853649A0 (fi) 1985-09-23
FI853649L FI853649L (fi) 1986-03-25

Family

ID=27417911

Family Applications (1)

Application Number Title Priority Date Filing Date
FI853649A FI853649L (fi) 1984-09-24 1985-09-23 Foerfarande foer framstaellning av farmaceutiskt aktiva 2-(pyridylalkensulfinyl)benzimidazoler.

Country Status (6)

Country Link
EP (1) EP0176308A3 (fi)
AU (1) AU568441B2 (fi)
DK (1) DK430285A (fi)
ES (1) ES8700666A1 (fi)
FI (1) FI853649L (fi)
MX (1) MX162676A (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2161160B (en) * 1984-07-06 1989-05-24 Fisons Plc Heterocyclic sulphinyl compounds
JO1406B1 (en) * 1984-11-02 1986-11-30 سميث كلاين اند فرينش لابوراتوريز ليمتد Chemical compounds
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
DE3777855D1 (de) * 1986-02-20 1992-05-07 Hoechst Ag Substituierte thienoimidazol-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer.
DE3773240D1 (de) * 1986-03-28 1991-10-31 Otsuka Pharma Co Ltd Hydrochinolinverbindungen, diese enthaltende zusammensetzungen und verfahren zu ihrer herstellung.
NZ222495A (en) * 1986-11-21 1991-04-26 Haessle Ab Benzimidazole derivatives and pharmaceutical compositions
SE8604998D0 (sv) 1986-11-21 1986-11-21 Haessle Ab Novel pharmacological compounds
FI91754C (fi) * 1986-12-02 1994-08-10 Tanabe Seiyaku Co Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi
US4839365A (en) * 1987-05-19 1989-06-13 Shinogi & Co., Ltd. Thienopyridine derivatives useful in treating gastric ulcers
DE3722810A1 (de) * 1987-07-10 1989-01-19 Hoechst Ag Substituierte benzimidazole, verfahren zu deren herstellung, diese enthaltende pharmazeutische zubereitungen und deren verwendung
AU617217B2 (en) * 1988-09-20 1991-11-21 Hisamitsu Pharmaceutical Co., Inc. Novel dibenz(b,e)oxepin derivatives
SE8804629D0 (sv) * 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
EG19302A (en) * 1988-12-22 1994-11-30 Haessle Ab Compound with gastric acid inhibitory effect and process for its preparation
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5274099A (en) * 1989-12-20 1993-12-28 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US5049674A (en) * 1989-12-20 1991-09-17 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
SE9002206D0 (sv) 1990-06-20 1990-06-20 Haessle Ab New compounds
WO1991019712A1 (en) * 1990-06-20 1991-12-26 Aktiebolaget Astra Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
US6437139B1 (en) 1997-05-06 2002-08-20 Pdi-Research Laboratories, Inc. Synthesis of pharmaceutically useful pyridine derivatives
CA2204580A1 (en) * 1997-05-06 1998-11-06 Michel Zoghbi Synthesis of pharmaceutically useful pyridine derivatives
WO2001062248A1 (en) 2000-02-24 2001-08-30 Kopran Research Laboratories Limited Orally administrable acid stable anti-ulcer benzimidazole derivatives
WO2002030920A1 (fr) * 2000-10-12 2002-04-18 Takeda Chemical Industries, Ltd. Composes derives de benzimidazole, leur procede de production et leur utilisation
WO2003027098A1 (fr) * 2001-09-25 2003-04-03 Takeda Chemical Industries, Ltd. Compose de benzymidazole, procede de production et d'utilisation de celui-ci

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
ZA825106B (en) * 1981-08-13 1983-04-27 Haessle Ab Novel pharmaceutical compositions
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
CA1259070A (en) * 1983-07-01 1989-09-05 Upjohn Company (The) Substituted 2-¬monoannelated(3,4-,4,5-, and 5,6-)- pyridylalkylenesulfinyl|-benzimidazoles

Also Published As

Publication number Publication date
DK430285D0 (da) 1985-09-23
FI853649L (fi) 1986-03-25
AU568441B2 (en) 1987-12-24
EP0176308A3 (en) 1987-04-01
EP0176308A2 (en) 1986-04-02
MX162676A (es) 1991-06-17
DK430285A (da) 1986-03-25
AU4669085A (en) 1986-04-10
ES547226A0 (es) 1986-11-16
ES8700666A1 (es) 1986-11-16

Similar Documents

Publication Publication Date Title
FI853649L (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva 2-(pyridylalkensulfinyl)benzimidazoler.
NO851949L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotetralinderivater.
NO853293L (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
NO851881L (no) Innretning for avgivelse av flyktige, virksomme materialer.
NO159089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater.
NO164097C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-hetero-aryl-tiazol-derivater.
NO854194L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende antracyklinglykosider.
DE3580304D1 (de) Arzneimittel.
NO871879D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktive heterocykliske forbindelser.
NO162238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater.
DE3576276D1 (de) Phenothiazine enthaltende arzneimittel.
NO864879D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiasolforbindelser.
NO871588D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske karboksamider.
NO169485C (no) Analogifremgangsmaate til fremstilling av farmakologisk aktive, substituerte benzamidderivater
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO165842C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
NO161559C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater.
NO861584L (no) Fremgangsmaate til fremstilling av terapeutisk aktive cyklopentyletere.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO161177C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive tioetere.
NO873514D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive forbindelser.
NO162072C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyridinderivater.
NO811360L (no) Fremgangsmaate for fremstilling av terapeutisk aktivt hydratisert picotamid.
NO891025D0 (no) Fremgangsmaate for fremstilling av nye, terapeutisk aktive sialosylglycerider.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: THE UPPJOHN COMPANY